Discover 1,546 paid clinical trials in Boulder, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,546
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Location: Denver CO, Salt Lake City UT, Dallas TX, Austin TX,
Sponsor: NiKang Therapeutics, Inc.
Sex: All
Age: 19+
Code: NCT06586957
Phase 1, Recruiting
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
for
Adult Spinal Deformity, Scoliosis, Kyphosis
Location: Denver CO, Phoenix AZ, Shreveport LA, La Jolla CA,
Sponsor: International Spine Study Group Foundation
Sex: All
Age: 18+
Code: NCT04888104
Recruiting
A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors
for
Solid Tumors, Adult
Location: Denver CO, Cleveland OH, Plantation FL
Sponsor: Hutchmed
Sex: All
Age: 18+
Code: NCT07228247
Phase 1, Phase 2, Recruiting
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Location: Denver CO, Dallas TX, Houston TX, Chicago IL, Eugene OR,
Sponsor: Institut de Recherches Internationales Servier
Sex: All
Age: 18+
Code: NCT06465953
Phase 3, Recruiting
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
for
MTAP-deleted Solid Tumors
Location: Denver CO, Irving TX, San Antonio TX, San Francisco CA,
Sponsor: Bayer
Sex: All
Age: 18+
Code: NCT06914128
Phase 1, Phase 2, Recruiting
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
for
Infusion Reactions
Location: Denver CO, Aurora CO, Omaha NE, Oklahoma City OK,
Sponsor: New York Blood Center
Sex: All
Age: 0+
Code: NCT01656603
Phase 2, Recruiting
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
for
Chronic Lymphocytic Leukemia (CLL),
Location: Denver CO, Salt Lake City UT, Duarte CA, Houston TX,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04830137
Phase 1, Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Location: Denver CO, Aurora CO, Oklahoma City OK, Fairway KS,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT05735184
Phase 1, Recruiting
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
for
Multiple Myeloma
Location: Denver CO, San Francisco CA, Seattle WA, Cleveland OH,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06500884
Phase 2, Recruiting
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
for
Multiple Myeloma
Location: Denver CO, Scottsdale AZ, Minneapolis MN, Rochester MN,